002382 蓝帆医疗
已收盘 02-01 15:00:00
资讯
新帖
简况
蓝帆医疗(002382.SZ)发布2022年业绩预告 三大主业持续发力
智通财经 · 01-30 20:01
蓝帆医疗(002382.SZ)发布2022年业绩预告 三大主业持续发力
1月30日蓝帆医疗现1笔折价10.77%的大宗交易 合计成交200.48万元
证券之星 · 01-30 16:59
1月30日蓝帆医疗现1笔折价10.77%的大宗交易 合计成交200.48万元
1月18日蓝帆医疗发生1笔大宗交易 成交金额303.24万元
证券之星 · 01-18
1月18日蓝帆医疗发生1笔大宗交易 成交金额303.24万元
1月16日蓝帆医疗现1笔折价11.51%的大宗交易 合计成交278.85万元
证券之星 · 01-16
1月16日蓝帆医疗现1笔折价11.51%的大宗交易 合计成交278.85万元
1月13日蓝帆医疗发布公告，其股东减持23.47万股
证券之星 · 01-13
1月13日蓝帆医疗发布公告，其股东减持23.47万股
蓝帆医疗(002382.SZ)股东北京信聿主动减持和被动稀释后股份变动比例达到1%
智通财经 · 01-13
蓝帆医疗(002382.SZ)股东北京信聿主动减持和被动稀释后股份变动比例达到1%
蓝帆医疗（002382）1月12日主力资金净买入394.76万元
证券之星 · 01-13
蓝帆医疗（002382）1月12日主力资金净买入394.76万元
1月6日蓝帆医疗发布公告，其股东减持199.08万股
证券之星 · 01-06
1月6日蓝帆医疗发布公告，其股东减持199.08万股
蓝帆医疗(002382.SZ)股东北京信聿累计减持5%股份
智通财经 · 01-06
蓝帆医疗(002382.SZ)股东北京信聿累计减持5%股份
蓝帆医疗（002382）12月27日主力资金净卖出1330.05万元
证券之星 · 2022-12-28
蓝帆医疗（002382）12月27日主力资金净卖出1330.05万元
蓝帆医药(002382.SZ)：抗原检测试剂盒供货较为紧张 无纺布价格目前比较稳定
智通财经 · 2022-12-19
蓝帆医药(002382.SZ)：抗原检测试剂盒供货较为紧张 无纺布价格目前比较稳定
蓝帆医疗最新公告：子公司微导管产品获批注册
证券之星 · 2022-12-16
蓝帆医疗最新公告：子公司微导管产品获批注册
蓝帆医疗(002382.SZ)子公司“微导管”产品获得中国NMPA批准注册
智通财经 · 2022-12-16
蓝帆医疗(002382.SZ)子公司“微导管”产品获得中国NMPA批准注册
蓝帆医疗（002382）12月15日主力资金净卖出1959.63万元
证券之星 · 2022-12-16
蓝帆医疗（002382）12月15日主力资金净卖出1959.63万元
蓝帆医疗(002382.SZ)拟非公开发行股票部分募投项目取得《企业境外投资证书》
智通财经网 · 2022-12-15
蓝帆医疗(002382.SZ)拟非公开发行股票部分募投项目取得《企业境外投资证书》
蓝帆医疗（002382）12月14日主力资金净卖出809.53万元
证券之星 · 2022-12-15
蓝帆医疗（002382）12月14日主力资金净卖出809.53万元
蓝帆医疗(002382.SZ)拟不超24.8亿元在上海投建科创总部及产业化基地项目
智通财经 · 2022-12-13
蓝帆医疗(002382.SZ)拟不超24.8亿元在上海投建科创总部及产业化基地项目
蓝帆医疗最新公告：拟不超过24.8亿元投建科创总部及产业化基地项目
证券之星 · 2022-12-13
蓝帆医疗最新公告：拟不超过24.8亿元投建科创总部及产业化基地项目
蓝帆医疗（002382）12月9日主力资金净买入1099.85万元
证券之星 · 2022-12-12
蓝帆医疗（002382）12月9日主力资金净买入1099.85万元
12月9日蓝帆医疗发布公告，其股东减持784.51万股
证券之星 · 2022-12-09
12月9日蓝帆医疗发布公告，其股东减持784.51万股
加载更多
公司概况
公司名称：
蓝帆医疗股份有限公司
所属行业：
专用设备制造业
上市日期：
2010-04-02
主营业务：
蓝帆医疗股份有限公司主要业务是健康防护手套的生产和销售。公司主要产品包括一次性医用手套、家用手套等，主要用于医疗检查和防护、食品加工、电子行业。蓝帆医疗是全球PVC健康防护手套行业的龙头企业，PVC健康防护手套年产销量及市场占有率均为全球第一。
发行价格：
35.00
{"stockData":{"symbol":"002382","market":"SZ","secType":"STK","nameCN":"蓝帆医疗","latestPrice":8.21,"timestamp":1675235007000,"preClose":8.1,"halted":0,"volume":8607087,"delay":0,"floatShares":1002000000,"shares":1007000000,"eps":-2.3909,"marketStatus":"已收盘","marketStatusCode":5,"change":0.11,"latestTime":"02-01 15:00:00","open":8.11,"high":8.22,"low":8.1,"amount":70317600,"amplitude":0.0148,"askPrice":8.22,"askSize":2283,"bidPrice":8.21,"bidSize":299,"shortable":0,"etf":0,"ttmEps":-2.3909,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1675301400000},"adr":0,"adjPreClose":8.1,"symbolType":"stock","highLimit":8.91,"lowLimit":7.29,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1007095048,"pbRate":0.76,"roa":"--","roe":"--","epsLYR":1.13,"committee":-0.186349,"marketValue":8268000000,"floatMarketCap":8222000000,"peRate":-3.433854,"changeRate":0.0136,"turnoverRate":0.0086,"status":0},"requestUrl":"/m/hq/s/002382","defaultTab":"news","newsList":[{"id":"2307202651","title":"蓝帆医疗(002382.SZ)发布2022年业绩预告 三大主业持续发力","url":"https://stock-news.laohu8.com/highlight/detail?id=2307202651","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2307202651?lang=zh_CN&edition=full","pubTime":"2023-01-30 20:01","pubTimestamp":1675080068,"startTime":"0","endTime":"0","summary":"智通财经APP讯，1月30日晚间，蓝帆医疗 发布2022年度业绩预告，全年预计归母净利润亏损2.9-4.1亿元，比上年同期下降125%-135%，基本符合预期。蓝帆医疗表示，虽然公司2022年业绩出现波动，但三大事业部持续发力，仍呈现出改善的曙光。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/868332.html","is_publish_highlight":false},{"id":"2307277139","title":"1月30日蓝帆医疗现1笔折价10.77%的大宗交易 合计成交200.48万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2307277139","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2307277139?lang=zh_CN&edition=full","pubTime":"2023-01-30 16:59","pubTimestamp":1675069152,"startTime":"0","endTime":"0","summary":"1月30日蓝帆医疗发生大宗交易，交易数据如下：大宗交易成交价格7.29元，相对当日收盘价折价10.77%，成交27.5万股，成交金额200.48万元，买方营业部为安信证券股份有限公司连云港郁州北路证券营业部，卖方营业部为华泰证券股份有限公司北京苏州街证券营业部。近三个月该股共发生19笔大宗交易，合计成交6.92万手，折价成交19笔。截至2023年1月30日收盘，蓝帆医疗报收于8.17元，上涨0.86%，换手率0.95%，成交量9.54万手，成交额7792.04万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2023013000009987.shtml","is_publish_highlight":false},{"id":"2304688880","title":"1月18日蓝帆医疗发生1笔大宗交易 成交金额303.24万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2304688880","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2304688880?lang=zh_CN&edition=full","pubTime":"2023-01-18 16:42","pubTimestamp":1674031353,"startTime":"0","endTime":"0","summary":"1月18日蓝帆医疗发生大宗交易，交易数据如下：大宗交易成交价格7.22元，相对当日收盘价折价9.86%，成交42万股，成交金额303.24万元，买方营业部为广发证券股份有限公司广州黄埔大道证券营业部，卖方营业部为华泰证券股份有限公司北京苏州街证券营业部。近三个月该股共发生18笔大宗交易，合计成交6.65万手，折价成交18笔。截至2023年1月18日收盘，蓝帆医疗报收于8.01元，下跌0.12%，换手率0.41%，成交量4.13万手，成交额3315.42万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2023011800011100.shtml","is_publish_highlight":false},{"id":"2303302482","title":"1月16日蓝帆医疗现1笔折价11.51%的大宗交易 合计成交278.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2303302482","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2303302482?lang=zh_CN&edition=full","pubTime":"2023-01-16 16:31","pubTimestamp":1673857887,"startTime":"0","endTime":"0","summary":"1月16日蓝帆医疗发生大宗交易，交易数据如下：大宗交易成交价格7.15元，相对当日收盘价折价11.51%，成交39万股，成交金额278.85万元，买方营业部为华泰证券股份有限公司无锡解放西路证券营业部，卖方营业部为华泰证券股份有限公司北京苏州街证券营业部。近三个月该股共发生17笔大宗交易，合计成交6.23万手，折价成交17笔。截至2023年1月16日收盘，蓝帆医疗报收于8.08元，上涨1.76%，换手率1.07%，成交量10.76万手，成交额8688.53万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2023011600009599.shtml","is_publish_highlight":false},{"id":"2303388656","title":"1月13日蓝帆医疗发布公告，其股东减持23.47万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2303388656","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2303388656?lang=zh_CN&edition=full","pubTime":"2023-01-13 23:00","pubTimestamp":1673622051,"startTime":"0","endTime":"0","summary":"1月13日蓝帆医疗发布公告《蓝帆医疗:关于股东股份变动比例达到1%的公告》，其股东北京信聿投资中心于2023年1月4日至2023年1月13日间合计减持23.47万股，占公司目前总股本的0.0233%，变动期间该股股价下跌0.38%，截止1月13日收盘报7.94元。股东增减持详情见下表：根据蓝帆医疗2022年三季报公布的十大股东详情如下：以上内容由证券之星根据公开信息整理，与本站立场无关。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2023011300029941.shtml","is_publish_highlight":false},{"id":"2303809472","title":"蓝帆医疗(002382.SZ)股东北京信聿主动减持和被动稀释后股份变动比例达到1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2303809472","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2303809472?lang=zh_CN&edition=full","pubTime":"2023-01-13 20:23","pubTimestamp":1673612625,"startTime":"0","endTime":"0","summary":"智通财经APP讯，蓝帆医疗(002382.SZ)发布公告，近日，公司收到北京信聿出具的《股份减持告知函》，北京信聿2022年11月4日至2023年1月13日通过大宗交易及集中竞价方式合计减持公司股份1007.05万股，同时因公司可转债转股导致北京信聿持股比例被动稀释，截至2023年1月13日，北京信聿主动减持和被动稀释后股份变动比例达到1%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/862041.html","is_publish_highlight":false},{"id":"2303821842","title":"蓝帆医疗（002382）1月12日主力资金净买入394.76万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2303821842","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2303821842?lang=zh_CN&edition=full","pubTime":"2023-01-13 09:10","pubTimestamp":1673572215,"startTime":"0","endTime":"0","summary":"截至2023年1月12日收盘，蓝帆医疗报收于7.95元，上涨1.79%，换手率0.96%，成交量9.65万手，成交额7577.37万元。近5日资金流向一览见下表：蓝帆医疗融资融券信息显示，融资方面，当日融资买入804.53万元，融资偿还815.13万元，融资净偿还10.6万元。蓝帆医疗主营业务：心脑血管业务、健康防护业务及急救护理业务。根据近五年财报数据，证券之星估值分析工具显示，蓝帆医疗行业内竞争力的护城河一般，盈利能力良好，营收成长性较差。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2023011300002485.shtml","is_publish_highlight":false},{"id":"2301278868","title":"1月6日蓝帆医疗发布公告，其股东减持199.08万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2301278868","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2301278868?lang=zh_CN&edition=full","pubTime":"2023-01-06 22:01","pubTimestamp":1673013664,"startTime":"0","endTime":"0","summary":"1月6日蓝帆医疗发布公告《蓝帆医疗:关于股东权益变动的提示性公告》，其股东北京信聿投资中心于2022年12月7日至2023年1月3日间合计减持199.08万股，占公司目前总股本的0.1977%，变动期间该股股价下跌12.22%，截止1月3日收盘报7.97元。股东增减持详情见下表：根据蓝帆医疗2022年三季报公布的十大股东详情如下：以上内容由证券之星根据公开信息整理，与本站立场无关。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2023010600022548.shtml","is_publish_highlight":false},{"id":"2301053221","title":"蓝帆医疗(002382.SZ)股东北京信聿累计减持5%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2301053221","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2301053221?lang=zh_CN&edition=full","pubTime":"2023-01-06 20:22","pubTimestamp":1673007752,"startTime":"0","endTime":"0","summary":"智通财经APP讯，蓝帆医疗(002382.SZ)公告，公司股东北京信聿自2022年1月17日-2023年1月3日累计减持公司股份5035.1万股，减持比例达5.00%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/858552.html","is_publish_highlight":false},{"id":"2294677856","title":"蓝帆医疗（002382）12月27日主力资金净卖出1330.05万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2294677856","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2294677856?lang=zh_CN&edition=full","pubTime":"2022-12-28 09:30","pubTimestamp":1672191059,"startTime":"0","endTime":"0","summary":"截至2022年12月27日收盘，蓝帆医疗报收于7.85元，下跌2.24%，换手率1.09%，成交量10.96万手，成交额8609.32万元。近5日资金流向一览见下表：蓝帆医疗融资融券信息显示，融资方面，当日融资买入1048.55万元，融资偿还381.78万元，融资净买入666.77万元。蓝帆医疗主营业务：心脑血管业务、健康防护业务及急救护理业务。根据近五年财报数据，证券之星估值分析工具显示，蓝帆医疗行业内竞争力的护城河一般，盈利能力良好，营收成长性较差。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2022122800001830.shtml","is_publish_highlight":false},{"id":"2292587846","title":"蓝帆医药(002382.SZ)：抗原检测试剂盒供货较为紧张 无纺布价格目前比较稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=2292587846","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2292587846?lang=zh_CN&edition=full","pubTime":"2022-12-19 14:11","pubTimestamp":1671430313,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，12月19日，蓝帆医药在投资者互动平台上表示，公司已与天津博奥赛斯生物科技股份有限公司、蓝怡科技集团股份有限公司就新冠抗原检测试剂盒的销售及营销达成合作，公司抗原检测试剂盒销售多为出口及B端采购。近期，国内居民对抗原试剂盒的需求快速增长，供货情况较为紧张。公司口罩、手套等个人防护产品较为紧俏，无纺布价格目前比较稳定。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/849265.html","is_publish_highlight":false},{"id":"2291804024","title":"蓝帆医疗最新公告：子公司微导管产品获批注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2291804024","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2291804024?lang=zh_CN&edition=full","pubTime":"2022-12-16 18:50","pubTimestamp":1671187808,"startTime":"0","endTime":"0","summary":"蓝帆医疗公告，子公司吉威医疗研发和生产的三类医疗器械产品“微导管”获得国家药监局的批准注册。截至2022年12月16日收盘，蓝帆医疗报收于8.67元，下跌0.12%，换手率1.45%，成交量14.48万手，成交额1.25亿元。根据近五年财报数据，证券之星估值分析工具显示，蓝帆医疗行业内竞争力的护城河一般，盈利能力良好，营收成长性较差。蓝帆医疗主营业务：心脑血管业务、健康防护业务及急救护理业务。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2022121600012615.shtml","is_publish_highlight":false},{"id":"2291021261","title":"蓝帆医疗(002382.SZ)子公司“微导管”产品获得中国NMPA批准注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2291021261","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2291021261?lang=zh_CN&edition=full","pubTime":"2022-12-16 18:44","pubTimestamp":1671187491,"startTime":"0","endTime":"0","summary":"智通财经APP讯，蓝帆医疗(002382.SZ)发布公告，近日，公司接到通知，子公司山东吉威医疗制品有限公司(以下简称“吉威医疗”)研发和生产的三类医疗器械产品“微导管”获得国家药品监督管理局(NMPA，以下简称“国家药监局”)的批准注册。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/848815.html","is_publish_highlight":false},{"id":"2291017307","title":"蓝帆医疗（002382）12月15日主力资金净卖出1959.63万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2291017307","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2291017307?lang=zh_CN&edition=full","pubTime":"2022-12-16 09:23","pubTimestamp":1671153796,"startTime":"0","endTime":"0","summary":"截至2022年12月15日收盘，蓝帆医疗报收于8.68元，下跌2.14%，换手率1.92%，成交量19.23万手，成交额1.68亿元。近5日资金流向一览见下表：蓝帆医疗融资融券信息显示，融资方面，当日融资买入1153.69万元，融资偿还1098.11万元，融资净买入55.58万元，连续3日净买入累计1352.25万元。蓝帆医疗主营业务：心脑血管业务、健康防护业务及急救护理业务。根据近五年财报数据，证券之星估值分析工具显示，蓝帆医疗行业内竞争力的护城河一般，盈利能力良好，营收成长性较差。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2022121600002770.shtml","is_publish_highlight":false},{"id":"2291061541","title":"蓝帆医疗(002382.SZ)拟非公开发行股票部分募投项目取得《企业境外投资证书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2291061541","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2291061541?lang=zh_CN&edition=full","pubTime":"2022-12-15 20:36","pubTimestamp":1671107799,"startTime":"0","endTime":"0","summary":"蓝帆医疗(002382.SZ)发布公告，公司分别于2022年10月28日和2022...","market":"sh","thumbnail":"https://img.zhitongcaijing.com/astock/19.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/astock/19.jpg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/848231.html","is_publish_highlight":false},{"id":"2291036804","title":"蓝帆医疗（002382）12月14日主力资金净卖出809.53万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2291036804","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2291036804?lang=zh_CN&edition=full","pubTime":"2022-12-15 09:13","pubTimestamp":1671066827,"startTime":"0","endTime":"0","summary":"截至2022年12月14日收盘，蓝帆医疗报收于8.87元，下跌3.27%，换手率2.39%，成交量23.93万手，成交额2.14亿元。近5日资金流向一览见下表：蓝帆医疗融资融券信息显示，融资方面，当日融资买入2917.85万元，融资偿还1956.41万元，融资净买入961.44万元。蓝帆医疗主营业务：心脑血管业务、健康防护业务及急救护理业务。根据近五年财报数据，证券之星估值分析工具显示，蓝帆医疗行业内竞争力的护城河一般，盈利能力良好，营收成长性较差。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2022121500002410.shtml","is_publish_highlight":false},{"id":"2291792197","title":"蓝帆医疗(002382.SZ)拟不超24.8亿元在上海投建科创总部及产业化基地项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2291792197","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2291792197?lang=zh_CN&edition=full","pubTime":"2022-12-13 20:42","pubTimestamp":1670935338,"startTime":"0","endTime":"0","summary":"其中一期项目为建设研发管理综合大楼及其配套楼，拟投资金额为7.70亿元；二期项目为建设高值医疗器械生产厂房及其配套设施，拟投资金额为17.10亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"http://www.zhitongcaijing.com/content/detail/846808.html","is_publish_highlight":false},{"id":"2291279212","title":"蓝帆医疗最新公告：拟不超过24.8亿元投建科创总部及产业化基地项目","url":"https://stock-news.laohu8.com/highlight/detail?id=2291279212","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2291279212?lang=zh_CN&edition=full","pubTime":"2022-12-13 20:40","pubTimestamp":1670935259,"startTime":"0","endTime":"0","summary":"蓝帆医疗公告，公司拟在上海市浦东新区上海国际医学园区投资建设蓝帆医疗科创总部及产业化基地项目，用于蓝帆医疗全球商业总部及高值产医疗器械生产基地，未来将承担蓝帆医疗冠脉介入、结构性心脏病、外周介入、神经介入和微创外科5个产品线的研发与生产功能，以及蓝帆医疗高端医疗器械的总部职能，包括不限于战略规划、投资并购、财务中心等。投资总金额不超过24.8亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2022121300012317.shtml","is_publish_highlight":false},{"id":"2290027650","title":"蓝帆医疗（002382）12月9日主力资金净买入1099.85万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2290027650","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2290027650?lang=zh_CN&edition=full","pubTime":"2022-12-12 09:07","pubTimestamp":1670807227,"startTime":"0","endTime":"0","summary":"截至2022年12月9日收盘，蓝帆医疗报收于9.2元，上涨3.49%，换手率5.0%，成交量50.05万手，成交额4.56亿元。近5日资金流向一览见下表：蓝帆医疗融资融券信息显示，融资方面，当日融资买入2637.5万元，融资偿还4024.27万元，融资净偿还1386.77万元。蓝帆医疗主营业务：心脑血管业务、健康防护业务及急救护理业务。根据近五年财报数据，证券之星估值分析工具显示，蓝帆医疗行业内竞争力的护城河一般，盈利能力良好，营收成长性较差。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2022121200000658.shtml","is_publish_highlight":false},{"id":"2290523325","title":"12月9日蓝帆医疗发布公告，其股东减持784.51万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2290523325","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2290523325?lang=zh_CN&edition=full","pubTime":"2022-12-09 23:01","pubTimestamp":1670598093,"startTime":"0","endTime":"0","summary":"12月9日蓝帆医疗发布公告《蓝帆医疗:简式权益变动报告书》，其股东北京信聿投资中心于2022年10月25日至2022年12月6日间合计减持784.51万股，占公司目前总股本的0.779%，变动期间该股股价上涨12.24%，截止12月6日收盘报9.08元。股东增减持详情见下表：根据蓝帆医疗2022年三季报公布的十大股东详情如下：以上内容由证券之星根据公开信息整理，与本站立场无关。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"source_url":"https://stock.stockstar.com/RB2022120900019644.shtml","is_publish_highlight":false}],"profile":{"ret":0,"listingDate":"2010-04-02","address":"山东省淄博市临淄区齐鲁化学工业区清田路21号","stockEarnings":[{"period":"1week","weight":0.0136},{"period":"1month","weight":0.0539},{"period":"3month","weight":-0.0453},{"period":"6month","weight":-0.0509},{"period":"1year","weight":-0.4581},{"period":"ytd","weight":0.0539}],"companyName":"蓝帆医疗股份有限公司","boardCode":"AI0035","perCapita":"8869股","boardName":"专用设备制造业","registeredCapital":"100709万元","compareEarnings":[{"period":"1week","weight":0.0062},{"period":"1month","weight":0.0633},{"period":"3month","weight":0.0958},{"period":"6month","weight":0.0179},{"period":"1year","weight":-0.0228},{"period":"ytd","weight":0.0633}],"survey":" 蓝帆医疗股份有限公司主要业务是健康防护手套的生产和销售。公司主要产品包括一次性医用手套、家用手套等，主要用于医疗检查和防护、食品加工、电子行业。蓝帆医疗是全球PVC健康防护手套行业的龙头企业，PVC健康防护手套年产销量及市场占有率均为全球第一。","serverTime":1675277317632,"listedPrice":35,"stockholders":"112920人(较上一季度增加4.41%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"CCBot/2.0 (https://commoncrawl.org/faq/)","isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.11.11","shortVersion":"4.11.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"蓝帆医疗(002382)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供蓝帆医疗(002382)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"蓝帆医疗,002382,蓝帆医疗股票,蓝帆医疗股票老虎,蓝帆医疗股票老虎国际,蓝帆医疗行情,蓝帆医疗股票行情,蓝帆医疗股价,蓝帆医疗股市,蓝帆医疗股票价格,蓝帆医疗股票交易,蓝帆医疗股票购买,蓝帆医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"蓝帆医疗(002382)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供蓝帆医疗(002382)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}